These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 30503138

  • 1. Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production.
    Malik M, Britten J, Borahay M, Segars J, Catherino WH.
    Fertil Steril; 2018 Dec; 110(7):1398-1407.e1. PubMed ID: 30503138
    [Abstract] [Full Text] [Related]

  • 2. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
    Islam MS, Protic O, Ciavattini A, Giannubilo SR, Tranquilli AL, Catherino WH, Castellucci M, Ciarmela P.
    Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
    [Abstract] [Full Text] [Related]

  • 3. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
    Janjusevic M, Greco S, Islam MS, Castellucci C, Ciavattini A, Toti P, Petraglia F, Ciarmela P.
    Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
    [Abstract] [Full Text] [Related]

  • 4. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
    Gueye NA, Mead TJ, Koch CD, Biscotti CV, Falcone T, Apte SS.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1631-1641. PubMed ID: 28323982
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M, Britten J, Cox J, Patel A, Catherino WH.
    Fertil Steril; 2016 Jan 01; 105(1):214-24. PubMed ID: 26409322
    [Abstract] [Full Text] [Related]

  • 6. Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
    Levy G, Malik M, Britten J, Gilden M, Segars J, Catherino WH.
    Fertil Steril; 2014 Jul 01; 102(1):272-281.e2. PubMed ID: 24825427
    [Abstract] [Full Text] [Related]

  • 7. Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium.
    Malik M, Catherino WH.
    Fertil Steril; 2012 Jun 01; 97(6):1287-93. PubMed ID: 22425196
    [Abstract] [Full Text] [Related]

  • 8. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
    Patel A, Malik M, Britten J, Cox J, Catherino WH.
    Fertil Steril; 2016 Apr 01; 105(4):1102-10. PubMed ID: 26776909
    [Abstract] [Full Text] [Related]

  • 9. Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression.
    Malik M, Mendoza M, Payson M, Catherino WH.
    Fertil Steril; 2009 May 01; 91(5 Suppl):2177-84. PubMed ID: 18555241
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL, Malik M, Levy G, Mendoza M, Catherino WH.
    Fertil Steril; 2012 Nov 01; 98(5):1299-307. PubMed ID: 22901846
    [Abstract] [Full Text] [Related]

  • 12. Functional evidence for two distinct mechanisms of action of progesterone and selective progesterone receptor modulator on uterine leiomyomas.
    Milewska G, Ponikwicka-Tyszko D, Bernaczyk P, Lupu O, Szamatowicz M, Sztachelska M, Pilaszewicz-Puza A, Koda M, Bielawski T, Zbucka-Kretowska M, Pawelczyk A, Tomaszewski J, Li X, Huhtaniemi I, Wolczynski S, Rahman NA.
    Fertil Steril; 2024 Aug 01; 122(2):341-351. PubMed ID: 38431184
    [Abstract] [Full Text] [Related]

  • 13. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells.
    Greco S, Islam MS, Zannotti A, Delli Carpini G, Giannubilo SR, Ciavattini A, Petraglia F, Ciarmela P.
    Reprod Biomed Online; 2020 Apr 01; 40(4):593-602. PubMed ID: 32276890
    [Abstract] [Full Text] [Related]

  • 14. Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
    Gilden M, Malik M, Britten J, Delgado T, Levy G, Catherino WH.
    Fertil Steril; 2012 Dec 01; 98(6):1557-62. PubMed ID: 22925684
    [Abstract] [Full Text] [Related]

  • 15. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
    Joseph DS, Malik M, Nurudeen S, Catherino WH.
    Fertil Steril; 2010 Mar 15; 93(5):1500-8. PubMed ID: 19328471
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
    Corachán A, Ferrero H, Aguilar A, Garcia N, Monleon J, Faus A, Cervelló I, Pellicer A.
    Fertil Steril; 2019 Feb 15; 111(2):397-407. PubMed ID: 30458994
    [Abstract] [Full Text] [Related]

  • 17. The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.
    Grudzien MM, Low PS, Manning PC, Arredondo M, Belton RJ, Nowak RA.
    Fertil Steril; 2010 Mar 01; 93(4):1290-8. PubMed ID: 19135664
    [Abstract] [Full Text] [Related]

  • 18. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells.
    Afrin S, Islam MS, Patzkowsky K, Malik M, Catherino WH, Segars JH, Borahay MA.
    Am J Obstet Gynecol; 2020 Nov 01; 223(5):733.e1-733.e14. PubMed ID: 32417359
    [Abstract] [Full Text] [Related]

  • 19. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
    Borahay MA, Vincent K, Motamedi M, Sbrana E, Kilic GS, Al-Hendy A, Boehning D.
    Am J Obstet Gynecol; 2015 Aug 01; 213(2):196.e1-8. PubMed ID: 25840272
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.
    Norian JM, Malik M, Parker CY, Joseph D, Leppert PC, Segars JH, Catherino WH.
    Reprod Sci; 2009 Dec 01; 16(12):1153-64. PubMed ID: 19700613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.